Login / Signup

Risks and Benefits of Janus Kinase Inhibitors in Rheumatoid Arthritis - Past, Present, and Future.

Jasvinder A Singh
Published in: The New England journal of medicine (2022)
Keyphrases
  • rheumatoid arthritis
  • disease activity
  • human health
  • interstitial lung disease
  • ankylosing spondylitis
  • risk assessment
  • systemic sclerosis
  • idiopathic pulmonary fibrosis